GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioptic 6850.TWO · TWD

N/A · Taipei Exchange · 🇹🇼 Taiwan

Compare

27.50

-2.83%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Bioptic

Its shares trade on Taipei Exchange under the ticker 6850.TWO. It has been listed since 10 November 2021. In the fiscal year to 31 December 2024, it reported revenue of TWD 202.7m and net income of TWD 22.7m. At that date it held total assets of TWD 596.4m and shareholders' equity of TWD 449.7m.

BiOptic Inc is a Taiwan-based company mainly engaged in research, development, production and sale of capillary electrophoresis apparatus and related consumables and nucleic acid detection reagents. The company is headquartered in Taipei, New Taipei. The company went IPO on 2021-11-10. The firm's main products include testing instruments, cassettes and reagents. The detection equipment includes Qsep100 series, Qsep1 series and Qsep400 series of capillary electrophoresis instruments for separation and detection of biomolecules. Cartridges include S1, S2, S3, F3 series for detecting different fragments of deoxyribonucleic acid (DNA), R1 and NR1 series for ribonucleic acid (RNA) detection, P2 series for protein detection and quantitative detection Q series. The reagents include polymerase chain reaction reagents, veterinary medicine-related reagents, human gene detection-related reagents and food-related reagents. The firm mainly provides its products in China, Hong Kong, Taiwan and other regions.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
10 Nov 2021

Leadership

Pay as last reported

  • Shouguan CaiChairman of the Board, General Manager
  • Xianliang JiDeputy General Manager-Research & Development, Director
  • Dezheng LiDeputy General Manager-Marketing Division
  • Xianqing LuDirector
  • Songjiong XuDirector
  • Yonglai ChenIndependent Director
  • Mr. Yongliang WangIndependent Director
  • Shuzhen XiaoIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company is headquartered in Taipei, Taiwan
  • Main products include capillary electrophoresis apparatus and related consumables
  • IPO occurred on 2021-11-10

Weaknesses

  • Sector and industry information are listed as N/A
  • Website is provided but no additional details about the site's functionality
  • Source description treats facts as untrusted

Opportunities

  • Products are sold in China, Hong Kong, and Taiwan regions
  • Main products include testing instruments, cassettes, and reagents
  • Detection equipment series include Qsep100, Qsep1, and Qsep400

Threats

  • Sector and industry information are missing
  • Source description is untrusted and may contain inaccuracies
  • No specific market trends or competitive analysis provided

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.